AptaBio Therapeutics Inc. (293780.KQ) KOE
7,090.00
-200(-2.74%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 251.64B |
| Enterprise Value | 239.98B |
| P/E Ratio | -12 |
| PEG Ratio | -0.15 |
| Price/Sales Ratio | 53 |
| Price/Book Ratio | 4.16 |
| Enterprise/Revenue | 49.85 |
| Enterprise/EBITDA | -12.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -4.42 |
| Operating Margin | -4.19 |
Management Effectiveness
| Return On Assets | -0.27 |
| Return On Equity | -0.34 |
Income Statement
| Revenue | 3.7B |
| Revenue/Share | 137.39 |
| Gross Profit | 874.45M |
| EBITDA | -15.05B |
| Net Income | -16.35B |
| Diluted EPS | -580.37 |
Balance Sheet
| Total Cash | 17.08B |
| Total Cash/Share | 634.58 |
| Total Debt | 4.42B |
| Total Debt/Equity | 0.09 |
| Current Ratio | 2.61 |
| Book Value Per Share | 1,753.23 |
Price History
| 52-Week Change | 1.82 |
| 52-Week High | 11,960 |
| 52-Week Low | 6,060 |
| Moving Average 50 Days | 7,271.8 |
| Moving Average 200 Days | 8,027.1 |
Statistics
| Average Volume | 148,087 |
| Shares Outstanding | 26.88M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | August 24, 2021 |
